Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 6,800 shares at $31.00 ($212K) on 2015-08-18, disclosed to the SEC on 2015-08-19.
Scheduled sale ($212k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.83 | 2,790 | $86K | 40.7% |
| 2 | $30.99 | 800 | $25K | 11.7% |
| 3 | $31.00 | 1,400 | $43K | 20.5% |
| 4 | $31.60 | 1,210 | $38K | 18.1% |
| 5 | $31.69 | 200 | $6K | 3.0% |
| 6 | $31.95 | 400 |
| $13K |
| 6.0% |
| Total | $31.11 avg | 6,800 | $212K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |